«Hearing Loss

Below is an extended Hearing Loss patents listing. Click here to return to the Hearing Loss main in depth entry.

Patents :
US Patent No.	Title
7399834	Anti-PRO1558 antibodies
7410480	Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
7410962	Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
7411040	PRO6182 polypeptides
7411047	PRO6097 antibodies
7411051	Antibodies to HDPPA04 polypeptide
7411054	25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
7415120	User adjustable volume control that accommodates hearing
7417115	PRO6027 polypeptides
7417123	PRO4399 Antibodies
7419497	Methods for treating ethmoid disease
7409068	Low-noise directional microphone system
7408042	Anti-PRO6181 antibodies
7400738	Acoustic module for a hearing aid device
7401519	System for monitoring exposure to impulse noise
7404221	Reciprocating movement platform for the external addition of pulses to the fluid channels of a subject
7404969	Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7405801	System and method for Pulfrich Filter Spectacles
7406352	Laminated electrode for a cochlear implant
7407744	Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors
7407778	Compounds, compositions and methods for treating neuropsychiatric disorders
7408032	PRO1188 polypeptides
7408033	PRO5995 polypeptides
7419674	Alpha virus-based cytomegalovirus vaccines
7421085	Hearing aid device or hearing device system with a clock generator
7421086	Hearing aid system
7427605	Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7427608	Protection against and treatment of hearing loss
7427611	Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
7428313	Method for correcting sound for the hearing-impaired
7429599	Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
7429614	Medicament containing an effector of the glutathione metabolism together with .alpha.-lipoic acid for treating diabetes mellitus
7429618	Potassium channel modulators
7429640	PRO6181 polypeptides
7429943	Analog to digital (A/D) conversion circuit have a low dynamic range A/D converter
7430299	System and method for transmitting audio via a serial data port in a hearing instrument
7427602	Sustained DNA delivery from structural matrices
7426414	Sound processing and stimulation systems and methods for use with cochlear implant devices
7421087	Transducer for electromagnetic hearing devices
7421759	Vacuum extraction apparatus for cleaning a surface
7423065	Therapeutic use of methionine-derivitives to reduce the toxicity of noise
7424122	Hearing instrument vent
7424123	Canal hearing device with tubular insert
7424124	Semi-permanent canal hearing device
7425331	Protein A methods of use
7425609	PRO4330 polypeptides
7425621	Antibodies against the PRO4401 polypeptide
7426279	Electromagnetic audio and data signaling transducers and systems
7430300	Sound production systems and methods for providing sound inside a headgear unit

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.